-
Published 9/24/2026
Falahee B, Apovian CM, Istfan N. Incretin-Based Therapies: A Testable Hypothesis Linking Incretin Signaling, Mitochondrial Redox, and OXPHOS Efficiency. Obesity (Silver Spring). 2026 Sep 24. PMID: 42782166.
-
Published 8/8/2026
Salim K, Cristancho C, Nimeri AA, Kim DW, Istfan N, Austen M, Apovian CM. Standardized inpatient protein-sparing modified fast as a bridge to metabolic/bariatric surgery in high-risk acutely ill adults with severe obesity. Surg Obes Relat Dis. 2026 Aug 08. PMID: 42697762.
-
Published 6/16/2026
Ryan DH, Fitch A, Kushner RF, Tronieri JS, Still CD, Apovian CM. Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. Obes Sci Pract. 2026 Jun; 12(3):e70159. PMID: 42311561.
-
Published 6/3/2026
Baer HJ, Cho J, Fay R, Apovian CM, McCarthy AC, Blood AJ, Samal L, Fisher NDL, Orav EJ, Wien M, Plutzky J, Block JP, Bates DW, Rozenblum R, Tucci M, McPartlin M, Oates M, McManus KD, Scirica BM. Engagement and Weight Change in an Online Weight Management Program in Clinical Settings: An Implementation Project. J Gen Intern Med. 2026 Jun 03. PMID: 42234371.
-
Published 5/9/2026
Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, Bonnet J, Butsch WS, Christensen S, Gianos E, Gulati M, Gupta A, Horn D, Kane RM, Saluja J, Sanndhi D, Stanford FC, Callahan EA. Erratum: Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obes Pillars. 2026 Jun; 18:100269. PMID: 42255462.